2002. Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA. Vaccine, 20:1699-701.Werzberger A, Mensch B, Nalin DR, Kuter BJ. Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 ...
Cost- effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies. PharmacoEconomics 2008;26(1):17-32.Anonychuk AM, Tricco AC, Bauch CT, Gilca V, Duval B, John-Baptiste A, et al. ...
Randomized trial of a vaccine regimen to prevent chronic HCV infection. N. Engl. J. Med. 384, 541–549 (2021). Article CAS PubMed PubMed Central Google Scholar Sofia, M. J. et al. Discovery of a β-d-2’-deoxy-2’-α-fluoro-2’-β-C-methyluridine nucleotide prodrug (PSI-7977...
In healthy adults >95% of those vaccinated with hepatitis A vaccines have protective antibody titers at 20 years after follow-up.124,125 Vaccine immunogenicity may be lower in those with chronic liver disease and immunosuppression. Persons with chronic hepatitis B/C infection or those with other ...
Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review [ J]. Expert Rev Vac- cines, 2016,7 : 1-23. [ Epub ahead of print].Czeschinski PA, Binding N, Witting U. Hepatitis A and hepatitis B vaccinations: immunogenicity of combined ...
A vaccine against HEV was recently licensed for use in China, but is not yet available in other countries; protection of water from fecal contamination, practicing good hygiene, and avoiding consumption of raw animal meats are still the primary preventive measures. Pegylated interferon-α and ...
Finally, an additional difficulty is the selection of those people at high risk to test the vaccine effectiveness, such as people requiring transfusions, injection drug users, and health care workers with frequent exposure to blood or bodily fluids. None of those groups would be feasible to ...
hepatitis B vaccine immunization program, cost analysis, incremental cost-effectiveness ratio, marginal effectiveness References [1] Shimakawa Y, Seck A, Nayagam S, et al. Screening strategies to prevent mother-to-child transmission of hepatitis B in sub-Saharan Africa[J]. Lancet Gastroenterol ...
Hepatitis C virus(HCV) infection is a prominent cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC), with up to 185 million chronically infected individuals worldwide, most of whom are undiagnosed and untreated.1,2A protective vaccine is not available, and those who cle...
Cost-effectiveness analysis of the universal use of hepatitis a vaccine in patients with chronic hepatitis Crupture of the spleenacute pancreatitischronic pancreatitissplenectomypancreatectomyBackground: Accessory spleen is a common congenital anomaly. There are currently no endoscopic ultrasound (EUS) ...